Top

Gepubliceerd in:

2013 | OriginalPaper | Hoofdstuk

28. Cardiac Rehabilitation and Secondary Prevention After Acute MI

Auteur : Arthur S. Leon, MS, MD, FACC, FACSM, FAHA

Uitgeverij: Springer New York

Abstract

Cardiac rehabilitation programs for patients following an acute MI originally consisted of early ambulation and moderate-intensity physical activity in the hospital and following discharge in order to counter the debilitating effects of bed rest. They subsequently have evolved into comprehensive, multifaceted, physician-supervised programs targeted not only at improving the patient’s functional capacity but also for preventing recurrent (secondary) coronary and other cardiovascular events. These cardiac rehabilitation/secondary prevention programs (CRSPP) currently include, in addition to supervised exercise training, intense risk factor modification, patient and family education about coronary heart disease, psychosocial counseling and support, and, if necessary, vocational and occupational counseling. CRSPP in addition to improving the patient’s functional capacity, and hence quality of life, have been shown by meta-analyses of randomized trials to reduce fatal and nonfatal cardiovascular recurrent events as well as all-cause mortality. The purpose of this chapter is to review the evolution of such programs, the research-based evidence of their benefits, and their recommended components and personnel.

vorige hoofdstuk Cardiopulmonary Resuscitation

volgende hoofdstuk Rheumatic Fever and Valvular Heart Disease

1 MET = the energy expenditure at rest or about 3.5 ml of 0₂ per minute.

Hellerstein HK. Cardiac rehabilitation: a retrospective view. In: Pollock ML, Schmidt DH, editors. Heart disease and rehabilitation. 2nd ed. New York: Wiley; 1986. p. 701–4.

Levine S, Lown B. “Arm Chair” treatment of acute coronary thrombosis. JAMA. 1952;148:1365–9.CrossRef

Taylor H, Henshel A, Brozek J, et al. Effects of bedrest on cardiovascular function and work performance. J Appl Physiol. 1949;2:223–39.PubMed

Saltin B, Blomquist G, Mitchell J, et al. Response to exercise after bed rest and after training. A longitudinal study of adverse changes in oxygen transport and composition. Circulation. 1968;33 Suppl 7:1–78.

Chobanian AV, Lille RD, Tereyak A, Blevins P. The metabolic and hemodynamic effects of prolonged bed rest in normal subjects. Circulation. 1974;49:551–9.PubMedCrossRef

Wenger NK. The physiologic basis for early ambulation after myocardial infarction. In: Wenger NK, editor. Exercise and the heart, cardiovascular clinics. Philadelphia: F.A. Davis; 1978. p. 107–15.

Bethell HJ. Cardiac rehabilitation from Hellerstein to the millennium. Int J Clin Pract. 2000;54:92–7.PubMed

Oldridge NB, Guyatt GH, Fisher ME, Rimm AA. Cardiac rehabilitation after myocardial infarction. Combined experience of randomized clinical trials. JAMA. 1988;260:945–50.PubMedCrossRef

O’Connor GI, Burning JE, Yusuf S, et al. An overview of randomized trials of rehabilitation with exercise after myocardial infarction. Circulation. 1989;66:1886–95.

10.

American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR). Guidelines for cardiac rehabilitation and secondary prevention programs. 4th ed. Champaign: AACVPR; 2004. pp. 1–280.

11.

Core components of Cardiac Rehabilitation/Secondary Prevention Programs, 2007. Updates. A scientific statement From the American Heart Association’s Exercise, Cardiac Rehabilitation and Prevention Committee. The Councils on Cardiovascular Nursing, Epidemiology and Prevention, and Nutrition, Physical Activity, Metabolism and the American Association of Cardiovascular and Pulmonary Rehabilitation. J Cardiopulm Rehabil. 2007;27:121–29.

12.

Smith SC, Benjamin EJ, Bonow RO, et al. AHA/ACCF Secondary prevention and risk deduction therapy for patients with coronary and other atherosclerotic vascular disease 2011. Updates. A guideline from the American Heart Association and the American College of Cardiology Foundation. Circulation. 2011;124:2458–73.PubMedCrossRef

13.

Roger VL, Go AS, Loyd-James DM, et al. Executive summary heart disease and stroke statistics – 2012 update. A report from the American Heart Association. Circulation. 2012;125:188–97.PubMedCrossRef

14.

Zullo MD, Jackson LW, Whalone CC, Dolansky MA. Evaluation of the recommended core components of cardiac rehabilitation practice. J Cardiopul Rehabil. 2012;32:32–40.

15.

Wenger NK, Froelicher ES, Smith LK, et al. Cardiac Rehabilitation as secondary prevention. Department of Health and Human Services, Agency for Health Care Policy and Research, and National heart, Lung, and Blood Institute, Publication No. 96–067, Oct 1995.

16.

Jolliffe JA, Rees K, Taylor RS, et al. Exercise-based rehabilitation for coronary heart disease. Coch Libr. 2003;3:1–91.

17.

Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of cardiovascular disease. A statement from the Council on Clinical Cardiology and Council on Nutrition, Physical Activity and Metabolism. Circulation. 2003;107:3009–16.CrossRef

18.

Lavie CJ, Thomas RJ, Squires RW, et al. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary heart disease. Mayo Clin Proc. 2009;84:373–83.PubMed

19.

Clark AM, Harrling L, Vandermeer B, McAllister FA. Meta-analysis: secondary prevention program for patients with coronary artery disease. Ann Inern Med. 2005;143:659–72.CrossRef

20.

Leon AS, Franklin BA, Costa F, et al. Cardiac rehabilitation and secondary prevention of coronary heart disease. An American Heart Association scientific statement from the Council on Clinical Cardiology in Collaboration with the American Association of Cardiovascular and Pulmonary Rehabilitation. Circulation. 2005;111:369–76.PubMedCrossRef

21.

AHA/ACC Guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular diseases. 2006 Update. Circulation. 2006;113:2363–72.

22.

Leon AS. Biological mechanisms for the cardioprotective effects of aerobic exercise. Am J Lifestyle Med. 2009;3(Suppl):32S–4.CrossRef

23.

Arnald SV, Spertus JA, Tang F, et al. Statin use in outpatients with obstructive coronary artery disease. Circulation. 2011;124:2405–10.CrossRef

24.

Lee KH, Jeong MH, Kim HM, et al. Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low-density lipoprotein cholesterol. J Am Coll Cardiol. 2011;58:1661–4.

25.

Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation. 2004;109:238–43.

26.

HattorI K, Ozaki Y, Ismail TF, et al. Impact of statin therapy on plaque characteristics as assessed by serial OCT, grayscale and integrated backscatter IVUS. J Am Col Cardiol. 2012;5:169–77.

27.

Mozaffarian D, Appel LJ, Van Horn L. Components of a cardioprotective diet: new insights. Circulation. 2011;123:2870–91.PubMedCrossRef

28.

NIH, NHLBI. Clinical guideline on the identification, evaluation, and treatment of overweight and obesity in adults. The evidence report. Bethesda: 1998 NIH Publication No. 98–4083; Sept 1998. http://www.nhlbi.nih.gov/guidelines/obesity/ob_gdlns.pdf. Accessed 3 Oct 2011.

29.

Jha P, Chaloupka FJ, Moore J, et al. Tobacco addiction. In: Jamison DJ, et al., editors. Disease control priorities in developing countries. 2nd ed. Washington, DC: International Bank for Reconstruction and Development/The World Bank; 2006. pp. 869–85.

30.

Chobanian AV, Bakris GL, Black HR, et al. National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension. 2003;421:206–1252.

31.

Sachs FM, Sverkey LP, Vollmer WM, et al. Effects on blood pressure of reduced sodium and the dietary approaches to stop hypertension (DASH) diet. N Engl J Med. 2001;344:3–10.CrossRef

32.

National Cholesterol Education Program Expert Panel on detection, evaluation and treatment of high blood cholesterol. Third Report of the NCEP on detection, evaluation, and treatment in adults (Adult Treatment Panel III final report). Circulation. 2002;106:3143–21.

33.

Grundy SM, Cleeman JI, Werz CNB, et al. Implications of recent clinical trials for the National Cholesterol Education Program. Adult Treatment Panel III guidelines. Circulation. 2004;110:227–39.PubMedCrossRef

34.

Leon AS, Bronas LG. Dyslipidemia and risk of coronary heart disease: role of lifestyle approaches for its management. Am J Lifestyle Med. 2009;3:257–73.CrossRef

35.

Robinson JG, Wang S, Smith BJ, Jacobson TA. Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol. 2009;53:316–22.PubMedCrossRef

36.

Jun M, Foote C, Lv J, et al. Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis. Lancet. 2010;375:1875–84.PubMedCrossRef

37.

AIM-HIGH Investigation. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. N Engl J Med. 2011;365:2255–67.CrossRef

38.

Sexual activity in middle aged post-MI Pt. Amsterdam, EA., Mason, D.T. Guidelines to patient management. In: Wenger NK, Hellerstein HK, editors. Rehabilitation of the coronary patient. New York: Wiley Medical Publication; 1978. pp. 19–51.

39.

Levine G, Steinke E, Baaken F, et al. Sexual activity and cardiovascular disease: a scientific statement from the American Heart Association. Circulation. 2012;125:1058–72.PubMedCrossRef

40.

Pate RR, Pratt M, Blair SN, et al. Physical activity and public health, a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;73:402–7.CrossRef

41.

U.S. Department of Health and Human Services. 2008 Physical activity guidelines for Americans. 2009. Available at: http://www.health.gov/paguidelines. Accessed 1 Apr 2009.

42.

Katzmarzyk PT, Church TS, Craig CL, Bouchard C. Sitting time and mortality from all causes, cardiovascular disease, and cancer. Med Sci Sports Exer. 2009;41:998–1005.CrossRef

43.

Mathews CE, George SM, Bowles HR, et al. Amount of time spent in sedentary behavior and cause-specific mortality in U.S. adults. Am J Clin Nutr. 2012;95:437–45.CrossRef

44.

Leon AS. Exercise following myocardial infarction. Current recommendations. Sports Med. 2000;29:301–11.PubMedCrossRef

45.

Borg G. Borg’s perceived exertion and pain scales. Champaign: Human Kinetics; 1998. p. 47.

46.

Pina IL, Apstein CS, Balady GL, et al. AHA scientific statement. Exercise and heart failure. Circulation. 2003;107:1210–25.PubMedCrossRef

47.

Pollard JA, Hines D. The role of exercise and lower extremities PAD. Cardiology. 2012;41(1):12–4.

48.

Williams MA, Haskell WL, Aides P, et al. AHA scientific statement. Resistance exercise in individuals with and without cardiovascular disease: 2007 update. Circulation. 2007;116:572–84.PubMedCrossRef

49.

Van Camp SP, Peterson RA. Cardiovascular complications of outpatient cardiac rehabilitation programs. JAMA. 1986;256:1160–3.PubMedCrossRef

50.

Franklin BA, Hogan P, Bonzheim K, et al. Safety of medically supervised outpatient cardiac rehabilitation exercise therapy: a 16-year follow-up. Chest. 1998;114:902–6.PubMedCrossRef

51.

King ML, Williams MA, Fletcher GF, et al. Medical directors’ responsibilities for outpatient cardiac rehabilitation/secondary prevention programs. A statement for health care professionals from the AACVPR and the AHA. J Cardiopul Rehab. 2005;25:315–20.CrossRef

AACVPR. AACVPR guidelines for cardiac rehabilitation and secondary prevention. 4th ed. Champaign: Human Kinetics; 2004.

Core Components of Cardiac Rehabilitation/Secondary Prevention Programs Updates. A Scientific Statement from the AHA and AACVPR. J Cardiopulm Rehabil. 2007;27:121–29.

King ML, Williams MA, Fetcher GF, et al. Medical Director responsibilities for outpatient cardiac rehabilitation; secondary prevention programs. A statement for health care professionals from the AACVPR and the AHA. J Cardiopul Rehab. 2005;25:315–20.CrossRef

Lavie CJ, Thomas RJ, Squires RW, et al. Exercise training and cardiac rehabilitation in primary and secondary prevention of coronary artery disease. Mayo Clin Prac. 2009;84:373–83.

Leon AS. Biological mechanisms for the cardioprotective effects of aerobic exercise. Am J Lifestyle Med. 2009;3 Suppl:32S–4.CrossRef

Titel: Cardiac Rehabilitation and Secondary Prevention After Acute MI
Auteur: Arthur S. Leon, MS, MD, FACC, FACSM, FAHA
Uitgeverij: Springer New York
Boek: Essential Cardiology
Print ISBN: 978-1-4614-6704-5

Elektronisch ISBN: 978-1-4614-6705-2

Copyright: 2013
DOI: https://doi.org/10.1007/978-1-4614-6705-2_28

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen